ReEmerge, Inc. exits stealth with an oversubscribed $37M Series A financing to advance its Cognitive Network Restoration Therapy for brain injuries.
PRIVATESep 15, 2026
Amount Raised
$37 Million
Round Type
Series A
MinnesotaBiotechnologyHealth Care
Investors
U.S. Venture PartnersOxford Science EnterprisesThe Vertical GroupIAG Capital Partners415 CapitalDendrion VenturesSanté
Description
ReEmerge, Inc. has closed an oversubscribed $37M Series A financing to support a clinical study evaluating their Cognitive Network Restoration Therapy for traumatic brain injury. The funds will also aid in advancing technology development and expanding operations. U.S
Who to call at ReEmerge, and when
A new round usually means ReEmerge is about to hire and buy. The teams that reach out first get the meeting.
An alert the day ReEmerge raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at ReEmerge, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ReEmerge. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
ReEmerge
Location
Minnesota, United States
About
ReEmerge, Inc. is a private MedTech company that focuses on innovating new ways to address cognitive impairments, particularly caused by traumatic brain injuries (TBI). Their proprietary technology, known as Cognitive Network Restoration Therapy (CNRT), targets neural networks to enhance cognitive recovery. The company has launched following a successful $37 million Series A funding round, aimed at advancing its clinical studies and technology development. With roots in extensive research, ReEmerge seeks to transform the recovery pathway for individuals affected by cognitive deficits.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ReEmerge raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.